These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9523765)

  • 1. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
    Pinelli A; Trivulzio S; Spezia R
    Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.
    Pinelli A; Trivulzio S; Ciapponi PM
    Fundam Clin Pharmacol; 1997; 11(4):346-55. PubMed ID: 9263765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects exerted by otilonium bromide administration on precipitated opioid withdrawal syndrome in rats.
    Pinelli A; Trivulzio S; Vignati S
    Toxicology; 1997 Sep; 122(1-2):23-37. PubMed ID: 9274799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of administration of phentonium bromide on opioid withdrawal syndrome in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    J Pharm Pharmacol; 1997 Dec; 49(12):1222-8. PubMed ID: 9466347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
    Caillé S; Espejo EF; Koob GF; Stinus L
    Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
    Pinelli A; Cighetti G; Trivulzio S
    Arzneimittelforschung; 2009; 59(2):72-8. PubMed ID: 19338137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
    Walsh SL; Strain EC; Bigelow GE
    Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
    Brugger S; Sánchez R; Brugger AJ; Martinez JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
    Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
    Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
    Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The potential antinarcotic effects of guanfacine].
    Marusov IV; Bogdanov EG; Marusova IB
    Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys.
    Katz JL
    Psychopharmacology (Berl); 1986; 88(3):392-7. PubMed ID: 3083461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine attenuates morphine withdrawal and subsequent drug sensitization in rhesus monkeys.
    Chen SQ; Zhai HF; Cui YY; Shi J; Le Foll B; Lu L
    Acta Pharmacol Sin; 2007 Apr; 28(4):473-83. PubMed ID: 17376286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
    Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
    Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.